Enterome collaborates with BIOASTER Institute

Enterome collaborates with BIOASTER Institute to provide new insights into mechanisms of potential microbiome-derived cancer immunotherapies

ENTEROME SA, a clinical-stage biopharmaceutical company, and BIOASTER, the French Institute for Technological Research in Infectious Diseases and Microbiology, today announced they have entered into a research collaboration.

The complete press release here.